Evaluation of the Effectiveness of Treating Insomnia with New Hypnotic Drugs - Eszopiclone and DORAs

Abstract Objective: Insomnia is a disorder that frequently occurs in the adult population and leads to impaired functioning or a reduced quality of life for those affected. It can also have a significant impact on cognitive processes later in life. Consequently, there is an ongoing search for alternatives to the medications currently used to treat this condition. The primary aim of this article is to summarize the latest scientific research on the use of eszopiclone and DORAs (dual orexin receptor antagonists) in the treatment of insomnia. Numerous studies indicate that patients suffering from this condition benefit from their use, both in cases of primary and secondary insomnia. Views: Insomnia is one of the most common reasons for patients visiting a doctor's office. Insomnia is a disorder characterized by a persistent feeling of dissatisfaction with the quantity or quality of sleep. Treatment of insomnia involves non-pharmacological methods, with cognitive-behavioral therapy being the most popular, as well as pharmacotherapy. In this article, we will analyze the effectiveness of treating insomnia with new sleep medications - eszopiclone and DORAs, based on the latest scientific works available on PubMed and Google Scholar. Conclusions: Eszopiclone and DORAs are effective alternatives to current drugs used in the pharmacotherapy of insomnia.